Kanglaite upregulates CD4+ T cells by inhibiting the expression of IL-1β in A549 cells
Background: Superior clinical efficacy and safety have been demonstrated in Kanglaite combined with cisplatin compared with cisplatin- or Kanglaite-alone treatment on advanced non-small cell lung cancer (NSCLC). However, the mechanism of how Kanglaite enhances antitumor effect of cisplatin is not f...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Innovation Publishing House Pte. Ltd.
2022-10-01
|
| Series: | STEMedicine |
| Subjects: | |
| Online Access: | https://stemedicine.org/index.php/stem/article/view/149 |